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Abstract 
Hemangiopericytoma is a rare tumor, mostly composed of pericytes of ramified 
appearance that are normally found all along the venules and capillaries. An 18-year-old 
female was admitted on March 17, 1997 to the Department of Infectious Diseases for 
fever, chills and failure to thrive. Physical examination revealed a palpable tumorous 
mass in the iliac region on the right. The patient was transferred to the Department of 
Surgery. Vaginal examination and echotomography of the abdomen and pelvis minor 
were performed and revealed the presence of an irregular, inhomogeneous tumorous 
formation of 8 cm in diameter in the pelvis minor, differentially diagnostic right ovary, 
i.e. acute adnexitis or perityphlitic tumor. After that, small intestine resection, tumor 
excision in toto, and appendectomy were performed on April 16, 1997. Pathohistological 
diagnosis was hemangiopericytoma and chronic appendicitis. The biological behavior of 
this tumor is difficult to predict on the basis of clinical and morphological parameters. In 
our patient, local tumor excision was not followed by adjuvant therapy. After ten years, 
the patient is well, healthy and a mother of two healthy children. 
 
Introduction 
Hemangiopericytoma is a rare tumor, first described in 1942, mostly composed of 
pericytes of ramified appearance that are normally found all along the venules and 
capillaries [1]. Hemangiopericytoma may arise anywhere. It is usually seen in adults, 
although infantile hemangiopericytoma is also recognized. The adult form is most 
common in the lower extremities, but also occurs in the pelvis or retroperitoneum or 
other sites [2]. Males and females show equal frequencies of occurrence. The development 
of hemangiopericytoma in the small bowel (ileum) is rare, with only few cases reported in 
the literature until the end of 2007. The clinical diagnosis and prognosis of the clinical 
and biological behavior of the tumor based on its morphological features still pose a 
considerable challenge [3–5]. Many hemangiopericytomas have an indolent behavior,  
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although some behave like other high-grade sarcomas. Immunohistochemically tumor 
cells stain with vimentin, but not with cytokeratin or epithelial membrane antigen. 
Vimentin is the main intermediate filament protein in mesenchymal cells, and therefore 
is of value in the differential diagnosis of undifferentiated neoplasms, including 
melanoma and sarcoma. Cytokeratin and epithelial membrane antigen are useful for 
marking tumors for squamous carcinoma and adenocarcinoma. Hemangiopericytoma is 
generally treated by extensive tumor excision with adjuvant radiotherapy and 
chemotherapy. 
Case Report 
An 18-year-old female was admitted on March 17, 1997 to the Department of Infectious Diseases of 
our hospital for fever, chills and failure to thrive. Physical examination revealed a palpable tumorous 
mass in the iliac region on the right. Laboratory findings are shown in table 1. Other laboratory findings 
were unremarkable. 
Suspicion of acute adnexitis was confirmed after gynecological examination. Vaginal and abdominal 
ultrasound were done as well. Abdomen and pelvis minor echotomographic examination (fig. 1) 
revealed an oval mass about 8 cm in diameter, isoechoic to the surrounding tissue, with sharp margins, a 
central hypoechoic zone (possible necrosis) and a thin hypoechoic halo. Echotomographically it was 
unclear whether the described mass originated from the ovary or the small bowel. 
After transfer to the Department of Surgery, laparotomy was performed which revealed a great 
vascular tumor of the ileum without infiltration to any adjacent organs or structure. The tumor did not 
break small bowel serosa. Small intestine resection, tumor excision in toto, and appendectomy were 
performed on April 16, 1997. There were no evident peritoneal or liver metastases. Also the right ovary 
and uterus were normal. Chronic appendicitis was an incidental finding. Macroscopically, a large 
(10 cm) shallow growth containing blood, surrounded by grayish to whitish tumor with visible nodules 
of cerebral consistency showing areas of hemorrhage, was found. 
Histological examination revealed a tumor composed of dense, round-oval and spindle cells focally 
palisading without forming fascicular architecture. The tumor cells bordering vascular and sinusoid 
areas varied in size. Tumor cells were separated from the lumina by Gomori and PAS positive zone 
(fig. 2). The number of mitosis was 4/10 high power fields. Immunohistochemically the tumor cells 
were positive for vimentin and negative for both types of actin, S-100, epithelial membrane antigen and 
antichimotrypsin. These findings confirmed a diagnosis of hemangiopericytoma, and the resection 
margin was clear. The resected appendix demonstrated chronic appendicitis. 
The patient made a satisfactory recovery and was discharged on postoperative day 8 with a 
recommendation to visit the oncologist. Adjuvant chemotherapy was not indicated, but considering the 
possibility of recurrences after long periods, patient monitoring was established: trimestrial controls 
during the first postoperative year (physical examination, routine laboratory tests and abdominal 
echotomography), semiannual controls during the next two years and after that annual controls. 
Computed tomography of the abdomen and chest roentgenogram, performed three years after the 
operation, were both normal. Physical examination, abdominal echotomography, abdominal computed 
tomography and barium enema made five and ten years after the operation were normal. Signs of 
recurrence and/or metastases were not determined either. During the period of monitoring, the patient 
gave birth to two healthy children. 
Discussion 
The biological behavior of hemangiopericytoma is difficult to predict on the basis of 
clinical and morphological parameters. Obviously there are low malignancy 
hemangiopericytomas, which are cured by extensive local excision, and high malignancy 
hemangiopericytomas frequently tending to recur and form distant metastases in spite of 
intensive therapy. There are also borderline or intermediary types where the clinical 
course is extremely difficult if not impossible to predict. According to current knowledge,  
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the prognostic factors include size of the primary tumor (>5 cm = poorer prognosis), 
number of mitosis (>4 per 10 high power fields), high grade of cellularity, immature or 
pleomorphic cells, necrosis, and hemorrhage [6, 7]. Hemangiopericytoma is generally 
treated by extensive tumor excision with adjuvant radiotherapy and chemotherapy, but 
radical surgery, if possible, is the mainstay of treatment for these neoplasms [3, 6, 8–10]. 
Hemangiopericytoma has some interesting clinical features. One of these is the rate of 
recurrence, which is as high as 52% of cases, mostly at distant sites, i.e. the lungs, liver and 
regional lymph nodes, necessitating long-term follow-up after surgical resection with 
additional treatment [8, 9]. However, effective chemotherapy regimens and molecular 
targeting therapy have not been established yet. Adjuvant chemotherapy is unproven but 
can be considered. For patients with advanced disease, various chemotherapeutic 
regimens may result in meaningful responses in a minority of patients. Several groups 
have observed that doxorubicin, alone or in combination with other agents, can achieve 
response [9]. Mulamalla et al. [11] described a favorable clinical benefit with sunitinib, an 
oral inhibitor of vascular endothelial grow factor receptor. Although some tumor 
regressions have occurred in response to radiotherapy, hemangiopericytomas generally 
are believed to be radioresistant [9]. Another interesting features are various 
paraneoplastic syndromes accompanying this tumor, such es hypoglycemia [8, 12], 
neurofibromatosis or von Recklinghausen disease [13]. Several mechanisms, such as the 
secretion of insulin-like substances, insulin-like growth factor II by the tumor, and the 
hyperutilization of glucose have been proposed as possible causes of tumor-related 
hypoglycemia. 
The development of hemangiopericytoma in the small bowel (ileum) is rare – to our 
knowledge, only few cases were reported in the literature until the end of 2007 [14]. 
However, none of the reports had patient monitoring as long as ours. In our patient, 
prognostic factors were borderline (size of primary tumor >5 cm, number of mitosis 4/10 
high power fields, with fields of necrosis and hemorrhages). Therefore and since the 
patient was expected to conceive in the near future, local tumor excision was not followed 
by adjuvant therapy. The patient was clinically followed up at 3-month intervals during 
the first year, every six months during the next two years and once a year during ten 
years. At 56 months postoperatively the patient was free from subjective discomfort, with 
normal clinical and laboratory findings, and pregnant. No paraneoplastic phenomena 
were noticed during monitoring. However, considering the high rate of 
hemangiopericytoma recurrence (Matsuda et al. [12] reported a patient with recurrences 
developing over a period of about ten years), long-term follow-up was required. Because 
of that, after the first birth, the patient was clinically followed once a year. After ten years, 
the patient was well, healthy and a mother of two healthy children. 
 
 
 
Table 1. Laboratory findings 
ESR 90–145 
L  15.7–17.7 × 10
9/l 
(PMN 70–83%; band 5–2%; ly 19–9%) 
E  4.18– 3.93 × 10
9/l 
Hb 88–80  g/l 
Plt 309–456  ×  10
9/l 
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Fig. 1. Abdomen and pelvis minor echotomography showing a well-demarcated tumorous formation. 
 
 
 
Fig. 2. Hemangiopericytoma (Gomori staining). 
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